This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Genomic Health Inc (GHDX)

NASDAQ: Health Care

Company Balance Sheet
Dec 2013 Dec 2012 Dec 2011 Dec 2010
Cash and Equivalents 33.28M 18.00M 32.87M 31.18M
Receivables 29.45M 22.25M 21.08M 14.31M
Inventories 0.00 0.00 0.00 0.00
Other Current Assets 0.00 0.00 0.00 0.00
Total Current Assets 144.99M 130.21M 129.00M 97.66M
Property, Plant & Equipment, Gross 61.81M 53.10M 43.73M 37.70M
Accumulated Depreciation & Depletion 43.52M 39.00M 34.28M 27.35M
Property, Plant & Equipment, Net 18.29M 14.10M 9.44M 10.34M
Intangibles 0.00 0.00 0.00 0.00
Other Non-Current Assets 13.75M 9.42M 4.56M 2.85M
Total Non-Current Assets 32.04M 23.52M 14.00M 13.20M
Liabilities & Shareholder Equity
Total Assets 177.03M 153.73M 143.00M 110.86M
Accounts Payable 5.16M 4.88M 7.02M 3.97M
Short Term Debt 0.00 0.00 0.00 0.00
Other Current Liabilities 570.00K 617.00K 685.00K 243.00K
Total Current Liabilities 29.83M 25.34M 26.14M 21.57M
Long Term Debt 0.00 0.00 0.00 0.00
Deferred Income Taxes 0.00 0.00 0.00 0.00
Other Non-Current Liabilities 2.22M 2.07M 1.50M 3.18M
Minority Interest 0.00 0.00 0.00 0.00
Total Non-Current Liabilities 2.22M 2.07M 1.50M 3.18M
Total Liabilities 32.05M 27.41M 27.64M 24.75M
Preferred Stock Equity 0.00 0.00 0.00 0.00
Common Stock Equity 144.98M 126.33M 115.36M 86.11M
Common Par 3.00K 3.00K 3.00K 3.00K
Additional Paid In Capital 345.34M 313.92M 281.15M 259.72M
Cumulative Translation Adjustment 0.00 0.00 0.00 0.00
Retained Earnings -170.27M -157.51M -165.76M -173.61M
Treasury Stock -30.11M -30.10M 0.00 0.00
Other Equity Adjustments 12.00K 15.00K -30.00K -10.00K
Total Capitalization 144.98M 126.33M 115.36M 86.11M
Total Equity 144.98M 126.33M 115.36M 86.11M
Total Liabilities & Stock Equity 177.03M 153.73M 143.00M 110.86M
Total Common Shares Outstanding 30.96M 29.95M 29.76M 29.01M
Preferred Shares 0.00 0.00 0.00 0.00
Treasury Shares 1.06M 984.07K 0.00 0.00
Basic Weighted Shares Outstanding 30.51M 30.33M 29.40M 28.82M
Diluted Weighted Shares Outstanding 30.51M 32.15M 30.75M 29.65M
Number of Employees 684 612 511 472
Number of Part-Time Employees 0 0 0 0

GHDX Genomic Health Inc

Analysts Ratings for GHDX

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 4 4 4 4
Moderate Buy 0 0 0 0
Hold 4 4 3 3
Moderate Sell 1 1 1 1
Strong Sell 1 1 1 1

Brokerage Partners

GHDX Chatter

Select the service that is right for you!

Action Alerts PLUS

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Growth Seeker

Bryan Ashenberg, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Options Profits

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
Top Rated Stocks Top Rated Funds Top Rated ETFs